Results

Total Results: 3,709 records

Showing results for "design sample size".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
    October 01, 2012 - and specificity.50 For the other Key Questions, we combined studies in a meta-analysis if the study design … methodological quality was assessed using different tools depending on the Key Question and study design … find a statistically significant difference in pregnancy outcomes appears more dependent on study design … Differences may have also resulted due to study design: in the ACHOIS trial, participants did not receive
  2. integrationacademy.ahrq.gov/sites/default/files/2025-07/MOUD_Playbook_Environmental_Scan_2025.pdf
    January 01, 2025 - a Barrier to Care............................................................................. 33 Design … oud-low-threshold-treatment Delivering Medications for Opioid Use Disorder in Primary Care: Environmental Scan 34 Design … Crisis Refocus the Playbook to Promote Low-Threshold Care Address Stigma as a Barrier to Care Design
  3. hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
    April 01, 2006 - ___APS-Def_Public.book 2 3 2 1 W h i t n e y A v e n u e • H a m d e n , C T 0 6 5 1 8 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7 D e f i n i t i o n s M a n u a l APS-DRGs ALL-PAYER SEVERITY-ADJUSTED DRG (APS-DRGS®) ASSIGNMENT FOR PUBLIC USE VERSION 22 ® PUB 4.5.2006 COPYRIGHT PAGE Copyright © 2006 HSS Inc. A…
  4. integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
    January 01, 2025 - the Moud treatment. 71 00:15:59.750 --> 00:16:26.929 Anna Ratzliff (she/her): So this is the basic design … In other words, because the design of the trial was an intent to treat design.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
    January 01, 2010 - SCIT: 8 Excluded 1,626 Reasons for Exclusion at Article Review Level* • Abstract only: 45 • Study design … The majority of studies had a moderate risk of bias due to the design choices that were made. … Most of the studies had small sample sizes; so, relevant statistical information on continuous outcomes … The RCTs should be conducted with attention to the design elements that reduce bias, such as clear … How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/hiv-sexually-transmitted-diseases-behavioral-counseling-1996
    January 01, 1996 - number of persons injecting drugs or the frequency of drug use. 65 , 66 Due to difficulties in study design
  7. effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
    March 29, 2016 - Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update Draft review available for public comment from April 20, 2015…
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/B_Ae7DdLL7DNauBLXC-ptu
    June 01, 2003 - Staff of the funding agency and members of the USPSTF contributed to the study design, reviewed draft … One RCT with a crossover design showed that 6 weeks of therapy with clomipramine (a tricyclic antidepressant
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - comparisons were included for the outcome of neuropathy, but studies were at high risk for bias, with low samplesizes and poorly defined outcomes. … Evidence Table Author, Year Intervention Comparator(s) Study Design N, Population Duration Primary … comparisons were included for the outcome of neuropathy, but studies were at high risk for bias, with low samplesizes and poorly defined outcomes.
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
    September 30, 2024 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement Screening for Breast Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommendations See the Summary of Recommendations figure. IMPORTANCE Among all US women, breas…
  11. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
    April 30, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Breast Cancer: Screening April 30, 2024 Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
    March 18, 2014 - Study design is a key issue here, with unique models of care emerging at different institutions. … The section on design characteristics should summarize the level of the intervention and comparison … GQ3, excellent points about the lack of research done, the heterogeneity of models, and the study design … Efforts to design and evaluate survivorship care models must have assessment of outcomes/endpoints
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
    October 01, 2017 - Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking White Paper Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking Research White Paper Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking Prepared for: Agency …
  14. www.ahrq.gov/research/findings/nhqrdr/chartbooks/healthyliving/healthyliving-slides.html
    April 01, 2018 - Numbers of measures differ across groups because of sample size limitations. … Number of measures differs across groups because of sample size limitations.
  15. Slide 1 (ppt file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/presentations/2008update-full/slides.ppt
    August 01, 2009 - Slide 1 * Treating Tobacco Use and Dependence 2008 UPDATE U.S. Public Health Service Clinical Practice Guideline August 2009 * The following is a summary of the 2008 PHS Clinical Practice Guideline Update: Treating Tobacco Use and dependence which was released May 7, 2008. PHS * The following 222 slides ar…
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
    February 01, 2015 - Therefore, in the end, study questions, design, methodological approaches, and/or conclusions do not … Three were intended to be used by clinicians and one by service providers to support clinical care or design … Timeframe Report Style Process Reference List 1-7 days List of available evidence, sorted by study design
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/56vB_8UTTE_HjygLvJfYqM
    May 01, 2002 - This finding suggests that the mixed results may be explained in part by differences in adequacy of samplesizes among trials.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - Chicago-Area DEcIDE Center The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ’s Effective Health Care program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The DEcIDE netw…
  19. hcup-us.ahrq.gov/reports/UtilizFollowMedExpanSNHs.pdf
    December 16, 2020 - Research Design We used a difference-in-differences (DID) Poisson model to assess whether the pre-post
  20. www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
    January 01, 2024 - Methods Study Design We conducted a series of retrospective cohort studies to complete the study aims